These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 19143947)

  • 1. Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass.
    Guzzetta NA; Huch S; Fernandez JD; Tosone SR; Miller BE
    Paediatr Anaesth; 2009 Apr; 19(4):364-70. PubMed ID: 19143947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of recombinant coagulation factor VIIa in uncontrolled postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Moll JJ; Krajewski W; Jarosik P
    Pediatr Crit Care Med; 2004 May; 5(3):246-50. PubMed ID: 15115562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive postoperative bleeding and outcomes in neonates undergoing cardiopulmonary bypass.
    Guzzetta NA; Allen NN; Wilson EC; Foster GS; Ehrlich AC; Miller BE
    Anesth Analg; 2015 Feb; 120(2):405-10. PubMed ID: 25390280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
    Agarwal HS; Bennett JE; Churchwell KB; Christian KG; Drinkwater DC; He Y; Taylor MB
    Ann Thorac Surg; 2007 Jul; 84(1):161-8. PubMed ID: 17588404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of thrombin generation in neonates undergoing cardiopulmonary bypass.
    Guzzetta NA; Szlam F; Kiser AS; Fernandez JD; Szlam AD; Leong T; Tanaka KA
    Br J Anaesth; 2014 Feb; 112(2):319-27. PubMed ID: 24193321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass.
    Pychyńska-Pokorska M; Pągowska-Klimek I; Krajewski W; Moll JJ
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):987-94. PubMed ID: 21835642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease.
    Veldman A; Neuhaeuser C; Akintuerk H; Thul J; Gehron J; Schranz D; Michel-Behnke I
    Paediatr Anaesth; 2007 Dec; 17(12):1176-81. PubMed ID: 17986036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery.
    Wittenstein B; Ng C; Ravn H; Goldman A
    Pediatr Crit Care Med; 2005 Jul; 6(4):473-6. PubMed ID: 15982438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery.
    Tatoulis J; Theodore S; Meswani M; Wynne R; Hon-Yap C; Powar N
    Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):459-62. PubMed ID: 19542087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Prothrombin Complex Concentrate with Activated Factor VII Use for Bleeding Following Cardiopulmonary Bypass in Children.
    Benson JW; Hraska V; Scott JP; Stuth EAE; Yan K; Zhang J; Niebler RA
    World J Pediatr Congenit Heart Surg; 2023 May; 14(3):282-288. PubMed ID: 36919404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery.
    McCall P; Story DA; Karalapillai D
    Can J Anaesth; 2006 Sep; 53(9):926-33. PubMed ID: 16960271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
    Mitsiakos G; Papaioannou G; Giougi E; Karagianni P; Garipidou V; Nikolaidis N
    J Pediatr Hematol Oncol; 2007 Mar; 29(3):145-50. PubMed ID: 17356391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant activated factor VII for refractory bleeding after cardiac surgery--a retrospective analysis of safety and efficacy.
    von Heymann C; Redlich U; Jain U; Kastrup M; Schroeder T; Sander M; Grosse J; Ziemer S; Koscielny J; Konertz WF; Wernecke KD; Spies C
    Crit Care Med; 2005 Oct; 33(10):2241-6. PubMed ID: 16215377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the structural and mechanical effects of procoagulant agents on neonatal fibrin networks following cardiopulmonary bypass.
    Nellenbach K; Guzzetta NA; Brown AC
    J Thromb Haemost; 2018 Nov; 16(11):2159-2167. PubMed ID: 30182421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The use of recombinant activated factor VII for blood loss after cardiovascular surgery].
    Gong ZY; Gao CQ; Xiao CS; Li BJ; Ma XH; Zhang CM
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(19):1497-501. PubMed ID: 19094631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.